Public Alert No. 26/2026 – WHO Alert on Substandard ACCUPAQUE (Iohexol), OMNIPAQUE (Iohexol) and VISIPAQUE (Iodixanol) in all WHO regions
The National Agency for Food and Drugs Administration and Control (NAFDAC) is notifying Healthcare providers and the public of multiple batches of substandard ACCUPAQUE, OMNIPAQUE, and VISIPAQUE solutions for injection presented in 100 ml polypropylene containers identified in Ireland and reported to WHO by the Health Products Regulatory Authority (HPRA), Ireland, in March 2026. A […]
Public Alert No. 025/2026 -Alert on the Recall Specific Batches of Antacid (Citro-Soda regular) in South Africa
The National Agency for Food and Drug Administration and Control (NAFDAC) has been notified by the South African Health Products Regulatory Authority (SAPHRA) of the recall of specific batches of Citro-Soda Regular following a potential contamination risk identified at the Adcock Ingram Clayville manufacturing facility in Johannesburg. Citro-Soda is an effervescent urinary alkalinizer and gastric […]
Press Release On NAFDAC Findings On Extended Shelf-Life Of Bread (BON)
NATIONAL AGENCY FOR FOOD AND DRUG ADMINISTRATION AND CONTROL INVESTIGATION UNUSUAL EXTENDED SHELF-LIFE OF BREAD (BON): THE MANUFACTURER IS IN COMPLIANCE INTRODUCTION: On April 13, 2026, an internet blogger complained via the social media that a loaf of bread that remained from the ones supplied to her for sale has been kept for over two […]
The Pharmaceutical Industry and the Impact of the 5 + 5 Policy
Nigeria’s pharmaceutical manufacturing sector is undergoing a systemic evolution towards self-sufficiency, improving access to good quality and affordable medicines, strengthening drug security, and driving economic growth among other benefits. Historically, the nation has grappled with a 70% dependency on imported medicines, leaving the healthcare system vulnerable to global supply chain disruptions and the influx of […]
NAFDAC becomes the 24th member of the International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use
The National Agency for Food and Drug Administration and Control (NAFDAC), Nigeria, has officially been admitted as a Member of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). The confirmation was made during the 51st ICH Assembly held in person on 18–19 November 2025 in Singapore. Alongside NAFDAC, the […]
Pharmaceutical Traceability & Supply Chain Monitoring
Securing the Journey of Medicines — From Manufacturer to Patient Medicines that are diverted, expired, or simply unavailable when needed cost lives. Traceability — the ability to track pharmaceutical products across every step of the supply chain, from manufacturer to point of care — is Nigeria’s strategic response to a supply chain that has long […]
NAFDAC’s WHO ML3 Re-Benchmarking Success: Sustaining Regulatory Excellence
In the dynamic world of global health, the ability to ensure the safety, quality, and efficacy of medical products is the cornerstone of public trust. For the National Agency for Food and Drug Administration and Control (NAFDAC), this commitment has reached a new milestone. Nigeria is the first National Regulatory Authority (NRA) in Africa to […]
NAFDAC Introduces Improved Med Safety App for Reporting Substandard and Falsified Medical Products
The National Agency for Food and Drug Administration and Control (NAFDAC) has introduced an improved version of the Med Safety App to strengthen the reporting of suspected Substandard and Falsified (SF) medical products in Nigeria. The upgraded app provides members of the public and healthcare providers with a faster, easier, and more secure platform […]
